115 related articles for article (PubMed ID: 14556301)
1. New research highlights effects of Medigap reform.
Austin B; DeFrancesco L
Find Brief; 2003 Oct; 6(4):1-5. PubMed ID: 14556301
[No Abstract] [Full Text] [Related]
2. Private, individual drug coverage in the current Medicare market.
Boccuti C; Moon M
Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
[No Abstract] [Full Text] [Related]
3. Medigap reform legislation of 1990: a 10-year review.
Fox PD; Snyder RE; Rice T
Health Care Financ Rev; 2003; 24(3):121-37. PubMed ID: 12894639
[TBL] [Abstract][Full Text] [Related]
4. Access to Medicare Part D gap coverage more scarce in 2007.
Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
[No Abstract] [Full Text] [Related]
5. Medigap regulation: lessons for health care reform.
Fox PD; Rice T; Alecxih L
J Health Polit Policy Law; 1995; 20(1):31-48. PubMed ID: 7738320
[TBL] [Abstract][Full Text] [Related]
6. Medicare reform and social insurance: the clashes of 2003 and their potential fallout.
Marmor TR; Hacker JS
Yale J Health Policy Law Ethics; 2005; 5(1):475-89. PubMed ID: 15742590
[No Abstract] [Full Text] [Related]
7. Can we afford all this?
Dickerson JF
Time; 2003 Dec; 162(23):48-51. PubMed ID: 14712554
[No Abstract] [Full Text] [Related]
8. Medicare's new drug plan: the right choice for you?
Consum Rep; 2005 Dec; 70(12):8. PubMed ID: 16299949
[No Abstract] [Full Text] [Related]
9. A sustainable future?: the role of premium subsidies in Medicare prescription drug plans.
Demchak C
Find Brief; 2007 Jan; 10(2):1-6. PubMed ID: 17302011
[No Abstract] [Full Text] [Related]
10. The impact of policy standardization on the Medigap market.
Rice T; Graham ML; Fox PD
Inquiry; 1997; 34(2):106-16. PubMed ID: 9256816
[TBL] [Abstract][Full Text] [Related]
11. Medigap: prevalence, premiums, and opportunities for reform.
Super N
NHPF Issue Brief; 2002 Sep; (782):1-23. PubMed ID: 12240698
[TBL] [Abstract][Full Text] [Related]
12. Medigap reform legislation of 1990: have the objectives been met?
McCormack LA; Fox PD; Rice T; Graham ML
Health Care Financ Rev; 1996; 18(1):157-74. PubMed ID: 10165030
[TBL] [Abstract][Full Text] [Related]
13. Six questions about the new Medicare bill.
Waller D
Time; 2003 Dec; 162(23):50-1. PubMed ID: 14712555
[No Abstract] [Full Text] [Related]
14. The black hole. Medicare's new drug law.
Bloice C; Watters M
Revolution (Oakl); 2004; 5(1):12-7. PubMed ID: 15052954
[No Abstract] [Full Text] [Related]
15. The new Medicare drug benefit: much ado about little?
Pauly MV
LDI Issue Brief; 2004; 9(4):1-6. PubMed ID: 15035261
[TBL] [Abstract][Full Text] [Related]
16. A whole new world?: pharmaceutical responses to the managed care revolution.
Balto DA
Food Drug Law J; 1997; 52(1):83-98. PubMed ID: 10346712
[No Abstract] [Full Text] [Related]
17. Senior prescription drug coverage: the state of the medigap markets in Massachusetts and New Hampshire.
Miller M; Turnbull N
Issue Brief (Mass Health Policy Forum); 2000; (7):1-34. PubMed ID: 12769116
[No Abstract] [Full Text] [Related]
18. More than the drug benefit.
Olsen GG
Rehab Manag; 2004 Apr; 17(3):42-4. PubMed ID: 15067925
[No Abstract] [Full Text] [Related]
19. Medicare reform opinions. All seniors gain benefits.
Scully T
Mod Healthc; 2003 Dec 22-29; 33(51):22. PubMed ID: 14723080
[No Abstract] [Full Text] [Related]
20. Bush tries to out-liberal the liberals on Medicare.
Miller M
Fortune; 2004 Jul; 150(1):60. PubMed ID: 15270461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
